Release
📈 Stocks
Innovent Biologics Adds 7 Drugs to China's 2026 National Reimbursement List
(just now)
Innovent Biologics secures NRDL inclusion for seven innovative products effective January 1, 2027, expanding its reimbursed lineup to 17 drugs and enhancing…